Jean-Philippe Oster
Hopitaux Civils de Colmar · 21 works · 762 citations · h-index 8
Top works
- Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial
- Genetics and specific immune response in allergy to birch pollen and food: Evidence of a strong, positive association between atopy and the HLA class II allele HLA-DR7☆☆☆★
- FASE-CPHG study: a panoramic snapshot of difficult-to-treat, severe asthma in French nonacademic hospitals
- Standardization of an Ash (Fraxinus excelsior) Pollen Allergen Extract
- The new face of non-small-cell lung cancer in men: Results of two French prospective epidemiological studies conducted 10 years apart
- Updated guidelines (2021) for management and follow-up of asthmatic patients of the French Society of Pneumology (SPLF) and the French Society of Pediatric Pneumology and Allergology (SP2A). Short version
- Health-related quality of life in elderly patients with advanced non-small cell lung cancer comparing carboplatin and weekly paclitaxel doublet chemotherapy with monotherapy
- FASE-CPHG Study: identification of asthma phenotypes in the French Severe Asthma Study using cluster analysis
- Phenotyping to Target Obstructive Sleep Apnoea Syndrom (OSAS) in adults patients with severe asthma
- Mid-term pulmonary sequelae after hospitalisation for COVID-19: The French SISCOVID cohort
- Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: Results from the IFCT-0802 trial.
- Anti–IL-4R versus anti–IL-5/5R after anti–IL-5/5R failure in asthma: An emulated target trial
- TG4010 immunotherapy combined with first-line therapy in advanced non-small cell lung cancer (NSCLC): phase IIb results of the TIME study
- FASE-CPHG Study: A Panoramic Snapshot of Severe Asthma in French Non-Academic Hospitals
- Real-world comparison of T2-biologics effectiveness in severe allergic asthma with nasal polyps
- Cost-utility analysis of maintenance therapy with either gemcitabine or erlotinib versus observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy in advanced NSCLC: IFCT-GFPC 0502-eco phase III study.
- FASE-CPHG Study: Identification of asthma phenotypes in the French Severe Asthma Study using cluster analysis
- FASE 2 - CPHG: Initial findings of an observational study of patients with severe asthma treated in French non-academic hospitals.
- P1-252: Epoetin beta treatment for anemia in lung cancer patients under chemotherapy: results of a large prospective cohort study
- P1.01-038 Prognosis Value of Body Mass Index (BMI) and Weight Loss at Diagnosis in Primary Lung Cancer: Results of KBP-2010-CPHG Study